COBAS TAQMAN ANALYZER

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a * report with the FDA on 2010-10-04 for COBAS TAQMAN ANALYZER manufactured by Roche Diagnostics Ltd..

Event Text Entries

[1660101] A customer in (b)(6) alleged to receive discrepant results when using the cobas (b)(6)tests. In the last 3 to 4 months, 3 titers ((b)(6)) have been over quantitated out of a total of 23,544 tests.
Patient Sequence No: 1, Text Type: D, B5


[8785537] The cobas taqman was returned and evaluated at roche. The baseline standard deviation of the available data are well below the algorithm noise parameter settings of the test definition files, indicating there is no fluorometer malfunction. All qc acceptance criteria were met when the qc tests were performed. The fluorometer and optical path checks were tested and passed the acceptance criteria. The performed investigations showed that the observed issues are not related to the analyzer. Therefore, the root cause of the incorrect results is suspected to be related to the elth algorithm and rare growth curve anomalies. The issue of elth baseline curve anomalies is still under investigation. However, curve anomalies could still occur and may rarely result in sudden titer shifts due to the software algorithm. (b)(4). Customers have the capability to review the growth curves for anomalies should they so desire. The impact to results is considered to be minor since the (b)(6) tests are intended to be used as a monitoring tests in conjunction with the clinical presentation and other laboratory markers as an aid in assessing viral response to antiviral therapy as measured by changes in plasma nucleic acid levels. In this context, changes in therapy would not be implemented if the titer was aberrant from previous titers, the overall clinical condition and other clinical parameters. Additionally, any retest result would likely generate an accurate, non-discrepant result because the occurrence of low fluorescence and baseline noise growth curves is random, rare and is not specimen related. In this case, the customer recognized the inconsistency and did not report it to the ordering physician. We recognize that this medical device report is being filed beyond the 30-day reporting timeframe as outlined within 21 cfr 803. 50. During a review of our mdr process, we determined that not all events that occurred ex-us were being assessed for mdr reportability within the united states. As a result, all potentially critical complaints (us and ex-us) filed going back to 01-jan-2008 were reassessed to determine if any of those cases represented an mdr reportable event. During the retrospective review, this event was identified as being mdr reportable. We are taking appropriate internal corrective actions to prevent recurrence of late filings.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number2243471-2010-00023
MDR Report Key1851295
Report Source*
Date Received2010-10-04
Date of Report2008-09-19
Date of Event2008-09-18
Date Mfgr Received2008-09-19
Date Added to Maude2011-05-02
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional0
Initial Report to FDA0
Report to FDA0
Event Location0
Manufacturer ContactVINCENT STAGNITTO
Manufacturer Street1080 US HWY 202
Manufacturer CityBRANCHBURG NJ 088763733
Manufacturer CountryUS
Manufacturer Postal088763733
Manufacturer Phone9082537569
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameCOBAS TAQMAN ANALYZER
Generic NameANALYZER, CHEMISTRY, MICRO, FOR CLINICAL USE
Product CodeJJF
Date Received2010-10-04
ID NumberAMPLILINK SOFTWARE V. 3.2.0
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerROCHE DIAGNOSTICS LTD.
Manufacturer AddressFORRENSTRASSE ROTKREUZ, ZUG CH-5343 SZ CH-5343 S


Patients

Patient NumberTreatmentOutcomeDate
10 2010-10-04

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.